Sign in

CIK 0000939767 · Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
operating
EIN
043257395
Phone
6508377000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-07 Aftab Dana CSO/EVP Disc & Trans Research Sale 10b5-1 −95,000 $25.00 $2.4M 520,990
2024-08-07 Aftab Dana CSO/EVP Disc & Trans Research Option exercise · Option (right to buy) 10b5-1 −95,000 0
2024-08-07 Haley Patrick J. EVP, Commercial Sale 10b5-1 −14,000 $25.50 $357K 341,036
2024-08-07 Hessekiel Jeffrey EVP, General Counsel & Sec Option exercise 10b5-1 +80,000 $24.41 $2.0M 710,325
2024-08-07 Hessekiel Jeffrey EVP, General Counsel & Sec Sale 10b5-1 −80,000 $25.97 $2.1M 630,325
2024-08-07 Hessekiel Jeffrey EVP, General Counsel & Sec Option exercise · Option (right to buy) 10b5-1 −80,000 20,000
2024-06-04 WYSZOMIERSKI JACK L Director Sale 10b5-1 −8,287 $22.00 $182K 349,499
2024-05-31 PAPADOPOULOS STELIOS Director Grant or award +18,838 1,279,416
2024-05-31 POSTE GEORGE Director Grant or award +18,838 232,745
2024-05-31 Freire Maria C Director Grant or award +18,838 99,257
2024-05-31 Heyman Tomas J. Director Grant or award +18,838 37,014
2024-05-31 Oliver Bob Director Grant or award +18,838 37,014
2024-05-31 WYSZOMIERSKI JACK L Director Grant or award +18,838 357,786
2024-05-31 Eckhardt Sue Gail Director Grant or award +18,838 34,262
2024-05-31 Beckerle Mary C Director Grant or award +18,838 34,262
2024-05-31 Smith Julie Director Grant or award +10,015 15,460
2024-05-31 Smith Julie Director Grant or award · Option (right to buy) +20,030 20,030
2024-05-31 JOHNSON DAVID EDWARD Director Grant or award · Option (right to buy) +42,767 42,767
2024-05-30 JOHNSON DAVID EDWARD Director Purchase +225,000 $20.76 $4.7M 1,525,730
2024-05-28 JOHNSON DAVID EDWARD Director Purchase +200,000 $20.32 $4.1M 1,300,730

Page 14 of 20 · 381 trades